Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
AstraZeneca deepens Summit ties on ADC-bispecific cancer combo testing pactÂ
Summit is currently developing Ivonescimab in combination with other drugs across several types of solid tumours.
Read Full Article
Pharma Tech
Novartis bets on autoimmune BiTEs through $7.8bn Abogen dealÂ
Unlike other therapies in this class, Abogen’s ABO2203 is designed to produce a T-cell engager protein in vivo through an mRNA-encoded system.
Read Full Article
Pharma Tech
Magazine: Keep it cool
In this issue: Key themes of CPHI 2026, the GLP-1 manufacturing shift, cold chain logistics, and more.
Read Full Article
Pharma Tech
Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity
Drug delivery’s next bottleneck is manufacturing capacity: scale, validation, and resilient supply chains.
Read Full Article
Pharma Tech
Sanofi and Regeneron expand immunology partnership to the tune of $8bn
The agreement will see Sanofi and Regeneron co-develop and co-commercialise four long-lasting antibodies.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
ET Pharma
Oct 3, 2026, 2:09 AM
US FDA extends review of Novo Nordisk's hemophilia drug over facility issues
The company was seeking the US Food and Drug Administration's approval for denecimig to treat adults and children with hemophilia A, with or without inhibitors, a rare condition that prevents the blood from clotting properly.
ET Pharma
Oct 3, 2026, 2:02 AM
Novartis strikes up to $7.8 billion mRNA deal with China's Abogen
Novartis will gain exclusive rights to Abogen's experimental drug, ABO2203, and options to license other therapies based on Abogen's RNA technology. It will also have the option to license additional experimental medicines developed using Abogen's RNA platform.
ET Pharma
Oct 2, 2026, 6:17 PM
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination
The companies said that they intend to begin with a late-stage trial testing the therapies in first-line triple-negative breast cancer
Pharma Tech
Oct 2, 2026, 1:30 PM
AstraZeneca deepens Summit ties on ADC-bispecific cancer combo testing pactÂ
Summit is currently developing Ivonescimab in combination with other drugs across several types of solid tumours.
Pharma Tech
Oct 2, 2026, 10:24 AM
Novartis bets on autoimmune BiTEs through $7.8bn Abogen dealÂ
Unlike other therapies in this class, Abogen’s ABO2203 is designed to produce a T-cell engager protein in vivo through an mRNA-encoded system.
ET Pharma
Oct 2, 2026, 10:02 AM
Sanofi bets up to $8 Bn on Regeneron’s Immunology pipeline in search for Dupixent successor
Sanofi will pay $1 billion upfront and up to $7 billion tied to development and regulatory milestones.. Both companies will share development and commercialisation costs, while profits from global sales will be shared on a 50:50 basis.
News
Latest industry coverage
Google News
Oct 3, 2026, 9:09 PM
President Mahama calls for greater investment in Africa’s pharmaceutical industry - GBC Ghana Online
President Mahama calls for greater investment in Africa’s pharmaceutical industry  GBC Ghana Online
Google News
Oct 3, 2026, 9:00 PM
Big pharma bets on KRAS G12D as oncology race intensifies - CHOSUNBIZ - Chosunbiz
Big pharma bets on KRAS G12D as oncology race intensifies - CHOSUNBIZÂ Â Chosunbiz
Google News
Oct 3, 2026, 8:36 PM
Bayer to invest $2.2 billion in new US manufacturing sites - thepharmaletter.com
Bayer to invest $2.2 billion in new US manufacturing sites  thepharmaletter.com
Google News
Oct 3, 2026, 8:36 PM
Italfarmaco and JCR Pharma ink license deal for JR-141 - thepharmaletter.com
Italfarmaco and JCR Pharma ink license deal for JR-141Â Â thepharmaletter.com
Google News
Oct 3, 2026, 7:43 PM
Germany’s Bayer to invest $2.2 bn in US pharma site - Macau Business
Germany’s Bayer to invest $2.2 bn in US pharma site  Macau Business
Google News
Oct 3, 2026, 7:26 PM
Which Drugs and Pharma Shaped Oncology in the First Half of 2026? Breaking Down FDA Approvals - Oncodaily
Which Drugs and Pharma Shaped Oncology in the First Half of 2026? Breaking Down FDA Approvals  Oncodaily
Google News
Oct 3, 2026, 6:42 PM
Five workers killed as boiler explodes at Sri City pharma unit in Tirupati - The Times of India
Five workers killed as boiler explodes at Sri City pharma unit in Tirupati  The Times of India
Google News
Oct 3, 2026, 5:53 PM
Pharma clusters power manufacturing strategy - Oman Observer
Pharma clusters power manufacturing strategy  Oman Observer
Google News
Oct 3, 2026, 3:41 PM
Double-Walled Insulated Boxes Market Forecast to 2035, Driven by Pharmaceutical Cold-Chain Demand - IndexBox
Double-Walled Insulated Boxes Market Forecast to 2035, Driven by Pharmaceutical Cold-Chain Demand  IndexBox
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer